FDA Inspection 806335 — Cobalt Pharmaceuticals, Inc.
The FDA completed an inspection of Cobalt Pharmaceuticals, Inc. on Oct 19, 2012 in Mississauga. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 19, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mississauga (Canada)